Australian regulators have warned of the risks of purchasing supplements from overseas in its latest safety advisory for products containing Ashwagandha (Withania somnifera).
Taiwan’s Food and Drug Administration will be setting consumption limits and usage warnings on ashwagandha and seven other botanicals that are used as food ingredients.
Our first Mind and Mood Interactive Broadcast has heard that regulators are failing to match consumer demand for natural products to aid mental well-being spanning cognition, sleep, stress and anxiety in the wake of the COVID-19 pandemic.
India’s Ministry of AYUSH has released a statement that advised against the use of ashwagandha leaves in Ayurveda and products for therapeutic purposes.